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Abstract 
Background: ALL1-fused from chromosome 1q (AF1q), originally considered as an oncogenic factor, has been impli-
cated in neuronal development; however, its upstream regulatory mechanisms in neural system remained elusive.
Results: Our study showed that REST (RE1 silencing transcription factor), a key transcription factor in neurodevelop-
ment, could down-regulate the gene expression of AF1q. The promoter assay identified a neuron-restrictive silencer 
element at −383 to −363 bp of human AF1q promoter. Electrophoretic mobility shift assay (EMSA) and chromatin 
immunoprecipitation (CHIP) confirmed the binding of REST to the NRSE in AF1q gene promoter. Additionally, the 
negative correlation between the expression levels of Af1q and Rest in mice neurodevelopment supported the nega-
tive regulation of AF1q by REST and the potential functions of AF1q in neurodevelopment.
Conclusion: These results demonstrate that REST regulates AF1q gene transcription through directly binding to a 
NRSE at −383 to −363 bp of AF1q promoter.
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Background
The AF1q gene was initially identified as a mixed line-
age leukaemia (MLL) fusion partner from an infant acute 
myelomonocytic leukemia patient carrying the t(1;11)
(q21;q23) translocation [1], which encoded a highly 
conserved 90 amino acid residues protein containing 
a MLLT11 motif and a nuclear export signal [2] with 
no similarity to other known proteins [1]. An increase 
in AF1q mRNA levels had been shown in leukemic and 
immature hematopoietic cells [1]. MiR-29b can regulate 
AF1Q gene expression and lower expression of miR-29b 
was associated with poor overall survival of acute mye-
loid leukemia [3]. AF1q had been regarded as an onco-
genic factor involved in thyroid oncocytic tumors, breast 
cancer and testicular germ cell tumors [4–8], though its 
function had not been well characterized. A recent study 
showed that AF1Q interacted with T cell factor 7 of Wnt 
signaling pathway to regulate CD44 and promoted breast 
cancer metastasis [9]. In addition to the proposed onco-
genic role, AF1q had been reported to play an important 
role in the development of neurons in the peripheral and 
central nervous systems [10]. The mouse Af1q, homo-
logue of human AF1q, was found to be significantly 
up-regulated during the neuronal production from neu-
ral stem/progenitor cells [11]. AF1q was differentially 
expressed during neuronal differentiation [10], but the 
underlying regulatory mechanisms in neurodevelopment 
were unknown.
REST (RE1 silencing transcription factor) regulates 
embryonic and neural stem cells by affecting their deriva-
tives [12–14] and participating in the self-renewal of 
neural stem cells [13] via regulating the transcription of 
target genes by binding to a 21-bp DNA element, which 
is called RE1-binding site/neuron-restrictive silencer ele-
ment (RE1/NRSE) during neurodevelopment [15]. It was 
found that the expression of REST was decreased in cul-
tured neurospheres derived from fetal Down syndrome 
(DS) brain [16] and in the brains of DS mouse models 
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[17]. REST was decreased in Alzheimer’s disease [10, 18]. 
REST, is expressed throughout early development [19] 
and acts as transcriptional silencer or activator, which is 
essential for the regulation of target genes during neu-
ronal development [20, 21]. Downregulation of REST 
during neurogenesis is necessary for proper neuronal dif-
ferentiation, while overexpression of REST in differenti-
ating neurons interferes in neuronal gene expression and 
causes axon guidance errors [22]. REST modulated the 
expression of genes that were critical in normal neuronal 
functions including neurotransmitter receptors, synap-
tic proteins, and ion channels proteins [15, 16]. Recent 
studies have demonstrated that in contrast to the role 
of REST in the repression of Rest target genes in in vitro 
cultured neuronal cells, as well as in non-neuronal cells 
outside of the brain, the CoRest binding site of Rest is 
dispensable for embryonic neurogenesis in vivo [12].
In the present study, we demonstrated that AF1q 
transcription could be down-regulated by REST. We 
also identified AF1q promoter sequence and demon-
strated that REST was a key transcriptional factor par-
ticipating in AF1q down-regulation via a NRSE site at 
−383 to −363  bp of human AF1q promoter. Further-
more, our study suggested that the expression of REST 
and AF1q were negatively correlated during neurode-
velopment, implying that AF1Q may be involved in 
neurodevelopment.
Results
REST inhibited human AF1q gene transcription
To investigate whether AF1q gene transcription was reg-
ulated by REST, the endogenous AF1q mRNA levels were 
determined by RT-PCR in cells transfected with REST 
expression plasmid pREST or its pSuper based silencing 
vector psiREST. The knock-down efficiency of psiREST 
was detected by real time PCR using SYBR Green gene 
expression assay. Silencing plasmid pSuper was per-
formed as control. Real time PCR confirmed that REST 
expression was reduced by psiREST to 37.57 ± 3.81 % of 
controls (Fig.  1a). REST mRNA level could be elevated 
or reduced by pREST or psiREST to 280.4 ±  8.331 and 
56.81 ± 4.813 % (p < 0.05; Fig. 1a). Similar results were 
obtained in the protein levels (p  <  0.05; Fig.  1b). Over-
expression of REST in HEK293 cells could significantly 
reduce AF1q mRNA levels to 42.31  ±  4.567  % of con-
trols (p  <  0.01; Fig.  1c). Furthermore, knockdown of 
REST could markedly increase the AF1q mRNA levels to 
256.1 ±  8.268  % (p  <  0.01; Fig.  1c). The data here indi-
cated that REST was a negative regulator of AF1q gene 
expression.
To further clarify the molecular mechanism of AF1q 
gene transcription, we cloned 1811-bp fragment located 
in the 5′-flanking region of the human AF1q gene 
(Fig. 1d) into promoterless vector pGL3Basic. TSS repre-
sents the first base on exon 1 from Ensemble transcript 
ENST00000368921, which is 2802-bp upstream of trans-
lation start codon. Thus, the expression of luciferase 
activity in cells transfected with this plasmid depended 
on the insertion and proper orientation of a functional 
promoter upstream of the firefly luciferase gene. Plasmid 
pAF1q promoter (−1349 to +462  bp) was transfected 
into HEK293 cells, and luciferase activity was measured 
by a luminometer to reflect AF1q promoter activity. 
Plasmid pAF1q promoter transfected cells had signifi-
cantly higher luciferase activity compared with controls 
(0.9445 ± 0.2401 compared with 0.08008 ± 0.006239 rel-
ative luciferase units, p < 0.05; Fig. 1e, f ), indicating that 
the 1.8-kb fragment contains the functional promoter 
region of the human AF1q gene.
To investigate whether AF1q gene transcription could 
be regulated by REST, we cotransfected HEK293 cells 
with REST expression plasmid and pAF1q promoter, and 
examined the promoter activity of human AF1q gene. A 
series of different mass ratio of REST and AF1q promoter 
were selected and screened for modulatory effects on 
dual-luciferase assay. The transfected mass ratio of REST 
to AF1q promoter was 1:3, 1:1, 3:1 and 5:1, respectively. 
The REST protein expression was determined by West-
ern blotting (Fig.  1g). Dual-luciferase assay showed that 
REST overexpression decreased AF1q promoter activity 
and the effects depended on the mass ratio of REST to 
AF1q promoter. We could see that the AF1Q promoter 
activity was reduce by 19.34  ±  8.499, 43.59  ±  6.122, 
53.24  ±  6.251, and 44.58  ±  7.531  % with increased 
expression of REST (p < 0.05; Fig. 1h). These results indi-
cated that the transcription of human AF1q gene could 
be down regulated by REST.
Identification of the functional NRSE site in AF1q gene 
promoter
Above data showed that AF1q gene promoter could 
be regulated by REST. Previous studied had shown 
that REST regulated the transcription of neural genes 
via binding to a NRSE site, a 21-bp consensus DNA 
sequence, which was present in the regulatory regions of 
neural genes. In this study, a computer-based transcrip-
tion factor-binding site search by the JASPAR database 
revealed that the 1811-bp 5′-flanking region contained 
two putative NRSE located at −383 to −363  bp and 
+422 to +442, which were the potential binding sites for 
REST. To identify the binding site, a series of luciferase 
reporter gene plasmids controlled by different upstream 
deletions of human AF1q gene promoter region were 
constructed (Fig.  2a, b). Each deletion construct was 
transfected into HEK293 cells with REST expression 
plasmid, respectively. Dual-luciferase assay showed that 
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REST significantly decreased AF1q promoter activity of 
pAF1qAluc, but had no significant effect on pAF1qBluc 
(Fig. 2c), indicating that the region of −383 to −363 bp 
of AF1q promoter might contain a NRSE. Moreover, 
the mutation of the NRSE site at −383 to −363  bp of 
pAF1qAluc abolished the effect of REST (Fig. 2e). These 
data indicated that the NRSE site located from −383 to 
−363 bp was essential for REST regulation.
To further confirm the NRSE located from −383 to 
−363  bp in AF1q promoter was the binding site for 
REST, EMSA and ChIP were performed. A 21-bp double-
stranded oligonucleotide probe containing the sequence 
of putative NRSE site in AF1q promoter was synthesized 
and end-labeled with IRDye 800 infrared dye. Consen-
sus NRSE, mutant consensus NRSE, and the putative 
NRSE site in AF1q promoter were also synthesized as 
cold probes. A shifted DNA–protein complex band was 
Fig. 1 REST inhibited human AF1q gene transcription. a Real time PCR showed that REST expression was decreased by psiREST. SYBR Green gene 
expression assay of REST was performed. 18S rRNA was used as the internal control. The values represent the mean ± SE (n = 3). *P < 0.05 by Stu-
dent’s t test. Con control. b RT-PCR showed that REST expression construct pREST increased REST mRNA expression, and REST knock down construct 
psiREST decreased REST mRNA expression. β-actin was used as the internal control. The values represented the mean ± SE (n = 3). *P < 0.01 by 
Student’s t test. c The knockdown effect of psiREST was verified in protein level by Western blot. REST was detected with anti-REST antibody. β-actin 
was used as the internal control. The values represented the mean ± SE (n = 3). *P < 0.01 by Student’s t test. d RT-PCR showed that AF1q mRNA was 
repressed by REST overexpression in HEK293 cells. β-actin was used as the internal control. The values represented the mean ± SE (n = 3). *P < 0.01 
by Student’s t test. e Genomic organization of AF1q gene. AF1q gene had two exons and one intron. TSS, transcription start site. f pAF1q-promoter 
contains the functional promoter of AF1q gene, containing the 1809-bp fragment from the human AF1q gene 5′UTR, was transfected into HEK293 
cells. +1 is the first base of the first exon. Dual-luciferase activity was measured by a luminometer 24 h after transfection. The values represented 
the mean ± SE (n = 3). *P < 0.01 by Student’s t test. g The expression of REST was examined by Western bolt. REST was detected with anti-REST 
antibody. Different mass ratios were marked under the Western blot figure. β-actin was used as the internal control. h AF1q gene promoter was 
inhibited by REST. REST was co-transfected with pAF1q promoter into HEK293 cells. Dual-luciferase activity was measured 24 h after transfection by 
a luminometer. The values represented the mean ± SE (n = 3). *P < 0.01 by Student’s t test
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detected after incubation of the labeled consensus NRSE 
probe with HeLa cell nuclear extract (lane 2 of Fig. 3a). 
The binding intensity of the shifted band was signifi-
cantly reduced by applying 100- or 200-fold molar excess 
of unlabeled consensus NRSE competitive oligonucleo-
tides (lane 4 and 5 of Fig. 3a). The incubation of 200-fold 
excessive mutant NRSE oligonucleotides had no compet-
itive effect in the shifted NRSE-REST band (lane 6 and 
7 of Fig. 3a). The addition of 100- and 200-fold excess of 
NRSE-AF1q, corresponding to the NRSE site from −383 
to −363  bp of the AF1q promoter region, reduced the 
NRSE-REST shifted band in a dosage-dependent man-
ner (lane 8 and 9 of Fig.  3a). The supershift band with 
the addition of anti-REST antibody further confirmed 
the specific binding between REST and AF1Q-NRSE site 
(Fig.  3b). These results further demonstrated that the 
NRSE-AF1q site at −383 to −363 in human AF1q pro-
moter was the binding site of REST.
To confirm that the NRSE-AF1q site verified in  vitro 
can actually bind to REST in vivo, ChIP was employed to 
pulldown the REST bound DNA. The anti-REST antibody 
actually immunoprecipitated REST protein as showed in 
Fig. 3c. Anti-RNA Polymerase II IP was used as positive 
control and IgG IP was used as negative control for ChIP. 
Purified DNA was then analyzed by PCR using Con-
trol Primers specific for the GAPDH promoter (Fig. 3d). 
PCR product was observed in the anti-RNA Polymerase 
II ChIP (lane 2, Fig. 3d), but not in the IgG ChIP (lane 3, 
Fig.  3d). ChIP-PCR results showed that REST antibody 
effectively immunoprecipitated the AF1q-NRSE site (lane 
2, Fig. 3e). And the ChIP band was greatly reduced in cells 
with REST knocked down (lane 5, Fig.  3e). AF1q-NRSE 
PCR product was also observed in the anti-RNA Poly-
merase II ChIP (lane 6, Fig. 3e) and not in the IgG ChIP 
(lane 3, Fig.  3e). AF1q promoter specific DNA was also 
observed in the Input (lane 1, Fig.  3e). Taken together, 
these data indicated that the NRSE site, corresponding to 
AF1q promoter −383 to −363 bp, was responsible for the 
down-regulation of AF1q gene by REST.
Af1q expression was negatively correlated with Rest 
in mice neurodevelopment
To investigate whether there are interactions between 
Af1q and Rest during neurodevelopment, we detected 
Fig. 2 Identification of the functional NRSE site in AF1q gene promoter. a Schematic diagrams of the AF1q promoter deletion constructs consisting 
of a 5′-flanking region with serial deletions cloned into the promoter-less vector plasmid pGL3-Basic in front of the luciferase reporter gene. Arrow 
indicated the direction of transcription. The numbers represented the end points of each construct. The positions of two putative NRSE sites were 
shown at the bottom. b The deletion plasmids were confirmed by sequencing and restriction enzyme digestion on a 1.5 % agarose gel. Vector 
size is 4.7 kb, and the AF1q gene 5′-flanking fragment inserts ranged from 0.6 to 1.8 kb. c HEK293 cells were co-transfected with REST expression 
vector and various AF1q promoter deletion constructs. Plasmid pRL-TK was used to normalize the transfection efficiency, and luciferase activity was 
measured at 24 h by a luminometer. The values represented the mean ± SE (n = 3). *P < 0.01 by Student’s t test. d pAF1qNRSEmut was made to 
contain the mutant NRSE site at −383 to −363 of p AF1qAluc, where (5′-TTAGCTGGGCGTGGTGGCGGA-3′) was mutated to (5′-TTAGCTGGaaGTctg-
GaaGGA-3′). e HEK293 cells were co-transfected with REST expression vector and AF1q promoter or pAF1qNRSEmut. Plasmid pRL-TK was used to 
normalize the transfection efficiency, and luciferase activity was measured at 24 h by a luminometer. The values represented the mean ± SE (n = 3). 
*P < 0.01 by Student’s t test
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mRNA levels of Af1q and Rest in the developing mice 
brains. RNA was extracted from normal mouse brains 
aging at embryonic days 13.5 and 18 and postnatal day 
1 (P1), P7, P14 and adult. The real-time RT-PCR results 
showed that mRNA levels of Af1q and Rest were coor-
dinately expressed with significant negative correlation 
during neurodevelopment (p =  0.0010, r = −0.8182 by 
Spearman correlation; Fig. 4a). The plot showed that the 
E18 measured point was deviated from the statistically 
supported tendency. These data further demonstrated 
that Af1q gene expression was negatively regulated by 
Rest in neurodevelopment.
Discussion
Our study here showed that REST, a key transcription 
factor in neurodevelopment, can down-regulate the gene 
Fig. 3 a EMSA was performed with IRDye 800-labeled NRSE site of AF1q promoter. Competition assays were performed by further adding different 
concentration of molar excess of unlabeled competitive oligonucleotides. b The addition of anti-REST antibody further shifted DNA–protein com-
plex band. Lower panel showed a longer running time. c The anti-REST antibody actually immunoprecipitated REST protein. Lane 1 was input. Lane 2 
was immunoprecipitates by anti-REST antibody. Lane 3 was immunoprecipitates by IgG antibody. And the lower bands were antibody heavy chain. 
d Anti-RNA polymerase II antibody was used to immunoprecipitate the GAPDH promoter region in CHIP assay in HEK293 cells. A pair of primers 
targeting GAPDH was used to amplify GAPDH. Signals amplified from input were used as size markers for PCR. IgG and H2O were used as negative 
controls. e Anti-REST antibody was used to immunoprecipitate the cross-linked REST-DNA complex in CHIP assay in HEK293 cells. A pair of primers 
targeting AF1q was used to amplify AF1q-REST. Signals amplified from input were used as size markers for PCR. IgG and H2O were used as negative 
controls. And anti-RNA Polymerase II antibody was used as positive control. Si-REST was from cells transfected with psiREST
Fig. 4 Af1q was negatively correlated with REST in mice neurodevel-
opment. a Quantitative RT-PCR was performed on cDNA templates 
prepared from normal mouse brain aging at embryonic days 13.5 
(E13.5) and 18.5 (E18.5); at postnatal P1, P7, and P14; and in adult 
mice. One to three mice were used in each time point as indicated by 
the numbers after the hyphens. P < 0.05 by Spearman correlation test
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expression of AF1q through directly binding to a NRSE 
at −383 to −363 bp of AF1q promoter. AF1q, originally 
considered as an oncogenic factor, is highly expressed 
in normal hematopoietic tissues, leukemic cell lines and 
neuronal cells in central nervous system [1, 10, 11, 23]. 
We can see that the promoter activity in pAF1q promoter 
is higher than the promoter activity in pAF1qAluc, indi-
cating the region of −1349 to −449 bp containing bind-
ing sites for some activators. The decrease of inhibitory 
effect by REST on pAF1QAluc suggested that the region 
of −1349 to −449  bp contained binding sites for REST 
cofactors.
Our study here elucidated the regulatory mechanism of 
AF1q by REST. REST, acting as transcriptional silencer or 
activator, was essential for the regulation of target genes 
during neuronal development [20, 21]. REST is required 
to repress the expression of neuronal genes in undiffer-
entiated neuronal tissue. Expression of REST was high-
est in embryonic stem cells, but it was decreased while 
ESCs were differentiated into neuronal stem cells, and 
it was at low level in mature adult neuronal cells [20]. In 
addition to participate in neurogenesis, Rest also medi-
ated the interactions between neuron and glia, which was 
associated with synaptic and neuronal network plasticity 
and homeostasis in the brain [24, 25]. All these indicated 
that REST is a key transcription factor in neurogenesis. 
As a target gene of REST, how AF1q functions in neuro-
genesis remains elusive. It will be interesting to examine 
the function of AF1q in neural stem cells and neuronal 
differentiation. It was reported that REST expression is 
a protective factor in aging and is decreased in neurode-
generative diseases such as Alzheimer’s disease [18]. It 
will be interesting to check the expression level of AF1q 
in some neurodegenerative diseases such as Alzheimer’s 
disease.
Overexpression of REST has been found in human 
medulloblastomas, glioblastoma and neuroblastomas 
[26], in which REST acted as an oncogene to main-
tain the stem character of neural cells [27]. REST can 
also act as a tumor suppressor in carcinomas including 
lung, breast and colon [27]. Though AF1q is regard as 
an oncogene, the expression level of AF1q is unknown 
in these cancers. It will be interesting to examine the 
expression of AF1Q in these cancers associated with 
REST dysfunction.
Conclusions
In summary, the current study provides a molecular 
model for REST in negative regulation of AF1q promoter 
activity and mRNA expression. These results will help to 
better understand the role of AF1q gene in in neural stem 
cells and neuronal differentiation.
Methods
Plasmids construction
The 5′-upstream region of human AF1q gene (−1349 
to +462  bp, pAF1q-promoter) was obtained by PCR of 
genomic DNA isolated from BAC-human-rp11 using 
a pair of primers (5′-CGGCTAGCAGGTCTCCACC 
CTGTCCCTGC-3′ and 5′-CCCTCGAGTTCCCTCCAC 
CCAGCTCTGGTC-3′). The first base of the first exon 
is referred as bp +1. Then they were cloned into pGL-
3basic vector (Promega, Madison, WI) containing fire-
fly luciferase reporter gene. Primers used to generate a 
series of promoter deletion plasmids were as follows: for-
ward primers, 5′-CGGCTAGCGTCAGGAGTTCCAG 
ACCAGC-3′ (pAF1qAluc), 5′-CGGCTAGCTGTAATCC 
CAGCTACTTGGG-3′ (pAF1qBluc), and reverse prim-
ers: 5′-CCCTCGAGCAGAAATGGCCTTGTTCTCT-3′. 
The pAF1qNRSEmut was constructed from pAF1QAluc 
in which the NRSE site 5′-TTAGCTGGGCGTGGTGG 
CGGA-3′ was mutated to 5′-TTAGCTGGaaGTctgGaa 
GGA-3′. All the constructs were verified by sequenc-
ing and restriction enzyme digestions. Human 
REST siRNA was generated using pSuper vec-
tor. The target sequence for human REST siRNA is 
GCTACAATACTAATCGATA. The two strands of 
RESTsuper sense (5′-gatccccGCTACAATACTAATCG 
ATAttcaagagaTATCGATTAGTATTGTAGCttttta) and 
RESTsuper antisense (5′-agcttaaaaaGCTACAATACTA 
ATCGATAtctcttgaaTATCGATTAGTATTGTAGCggg) 
were annealed and inserted into pSuper plasmid to gen-
erate the pSuper-REST construct. The vectors pREST 
were generated as previously described [28].
Cell culture, transfection and dual‑luciferase assay
HEK293 cells were cultured as previously described [29]. 
All cells were maintained at 37  °C in an incubator con-
taining 5 % CO2. All transfections were carried out with 
lipofectamine™2000 transfection reagent (Invitrogen) 
according to the manufacturer’s instructions. Luciferase 
activity was determined as previously described [21].
RT‑PCR
Total RNA was isolated from mouse brains or cells 
using TRIzol reagent (Invitrogen). The mRNA of REST 
and AF1q was quantified by TOYOBO R SYBR Green 
gene Expression Analysis kit (TOYOBO, Japan). Prim-
ers for real-time quantitative and semi-quantitative PCR 
were as follows: human AF1q (270  bp), forward, 5′-CCG 
CTCGAGGCCACCATGAGGGACCCTGTGAG-3′, and 
reverse, 5′-GGGGTACCGAGCAAGTCCAGTTCGAA 
G-3′; human REST (137  bp), forward, 5′-ACTCATCA 
CGGAGAACGCCC-3′, and reverse, 5′-GAGGCCACA 
TAACTGCACTG-3′; mouse Rest (244  bp), forward, 
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5′-CGAGTCTCAGGAAATTGATGA-3′, and reverse, 
5′-GCCGTTACCCACTCACTAATAC-3′; human and 
mouse β-actin (141  bp), forward, 5′-GACAGGATGCAG 
AAGGAGAT-3′, and reverse, 5′-TGATCCACATCTG 
CTGGAAGGT-3′. All animal protocols were approved by 
Shandong University Institutional Animal Care and Use 
Committee and by the Institutional Ethics Committee on 
Animal Research of Qilu Hospital.
EMSA and ChIP
The sense sequences of AF1qNRSE, consensus NRSE 
and mutant AF1qNRSE were 5′-AAAGATTAGCTGG 
GCGTGGTGGCGGATGCCTGTA, 5′-TTCAGCACCA 
CGGACAGCGCC, 5′-AAAGATTAGCTGGAAGTCTG 
GAAGGATGCCTGTA. EMSA and ChIP were per-
formed as previously described [28]. Chip-PCR was per-
formed using the DNA reversed from the cross-linked 
complex with a pair of primers (NRSE-AF1q:5′-GCCT 
CCGGTTGTACCACT-3′ and 5′-AGCGATTCTCCTGC 
CTCA-3′). Control primer specific for human GAPDH 
were 5′-TACTAGCGGTTTTACGGGCG-3′ and 5′-TC 
GAACAGGAGGAGCAGAGAGCGA-3′.
Western blot analysis
Western blot was performed as previously described [21]. 
Anti-REST antibody was from Millipore (#DAM15).
Data analysis
All experiments were repeated three to five times. In fig-
ures one representative picture was shown; quantifica-
tions were from three or five independent experiments. 
The values represent the mean  ±  SEM. The data were 
evaluated for statistical significance with Student’s t test 
analysis.
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